Gynae BT 2017

RTOG-0724 Lead Group: RTOG Ongoing studies Depth of stromal invasion and LVSI to be pathologically confirmed: • Positive capillary-lymphovascular space involvement and one of the following: • Deep third penetration • Middle third penetration, clinical tumor ≥ 2 cm • Superficial third penetration, clinical tumor ≥ 5 cm • Middle or deep third penetration, clinical tumor ≥ 4 cm POST-OP HIGH RISK CERVICAL CANCERS: Phase III Randomized Study of Concurrent Chemotherapy and Pelvic RT With or Without Adjuvant (Pacli + Carbo every 21 days x 4 cycles) Chemotherapy in High-Risk Patients with Early-Stage Cervical Carcinoma Following Radical Hysterectomy

SWOG NSABP NCIC NCCTG GOG ECOG CALGB ACOSOG SWOG RTOG NSABP NCIC NCCTG ECOG CALGB ACOSOG

To Date: 163 Target: 400 (09/15/14)

POST-OP INTERMEDIATE RISK CERVICAL CANCERS: Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemo-radiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated with Initial Radical Hysterectomy and Pelvic LND dissection

GOG-0263 Lead Group: GOG

Target: 534

GUSTAVE ROUSSY

THÈME DU DIAPORAMA